Effect / research focus
Studied clinically for inflammatory, nerve and metabolic outcomes; it lacks general medicinal approval.
Back to the peptide atlas
Tissue & repairPeptideIn clinical research
ARA-290 / Cibinetide
Non-haematopoietic erythropoietin-derived tissue-protective peptide
Also known as: ARA 290 · Cibinetide · pHBSP
How communities discuss it
Discussed in online communities in relation to the research focus described above. Anecdotes are not evidence of efficacy and are not use instructions.
Community reports are anecdotes, not evidence of efficacy or safety.
Why there is no mixing guide here
Reconstitution depends on the exact approved product, its official label and medical supervision. With unapproved substances, identity, concentration, sterility and stability are often unknown. A universal step-by-step guide would therefore be unsafe.
Primary sources
The linked regulator and trial-register sources support the current status summary.